Tokyo Tape
Sign in
← Soiken Holdings

Quarterly report · Q1

2385.TEDINET S100PI50
Period2022-07-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥2.2bn2022-07-01 → 2022-09-30Cons.Net sales
Revenue¥9.3bn2021-07-01 → 2022-06-30Cons.Net sales (5-year summary)
Revenue¥2.6bn2021-07-01 → 2021-09-30Cons.Net sales
Operating income¥46m2022-07-01 → 2022-09-30Cons.Operating income
Operating income¥64m2021-07-01 → 2021-09-30Cons.Operating income
Ordinary income¥46m2022-07-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥1.3bn2021-07-01 → 2022-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥110m2021-07-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥46m2022-07-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥109m2021-07-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥14m2022-07-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥810m2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥83m2021-07-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥16m2022-07-01 → 2022-09-30Cons.Profit loss
Net income¥86m2021-07-01 → 2021-09-30Cons.Profit loss
Total assets¥7.9bnat 2022-09-30Cons.Assets
Total assets¥8.5bnat 2022-06-30Cons.Assets
Total assets¥7.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.2bnat 2022-09-30Cons.Liabilities
Total liabilities¥1.6bnat 2022-06-30Cons.Liabilities
Net assets / equity¥6.7bnat 2022-09-30Cons.Net assets
Net assets / equity¥6.8bnat 2022-06-30Cons.Net assets
Net assets / equity¥6.1bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥5.0bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥6.0bnat 2022-06-30Cons.Cash and deposits
EPS (basic)¥0.532022-07-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥3.162021-07-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.3%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 45
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30¥600,000
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2022-09-30¥600,000
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥77m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2022-09-30¥89m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2022-09-30¥89m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2022-09-30−¥13m
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2022-09-30¥282m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue2022-07-01 → 2022-09-30¥732m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2022-09-30¥732m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2022-09-30−¥184m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue2022-07-01 → 2022-09-30¥138m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2022-09-30¥138m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2022-09-30¥23m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue2022-07-01 → 2022-09-30¥148m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2022-09-30¥148m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2022-09-30¥15m
—segment totalrevenue2022-07-01 → 2022-09-30¥2.2bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥2.2bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥123m
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥2m
Reconciling Itemsreconcilingrevenue external2021-07-01 → 2021-09-30¥600,000
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥3m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥82m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue2021-07-01 → 2021-09-30¥72m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2021-07-01 → 2021-09-30¥72m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2021-07-01 → 2021-09-30−¥18m
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2021-07-01 → 2021-09-30¥1.4bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2021-07-01 → 2021-09-30¥1.4bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2021-07-01 → 2021-09-30¥316m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue2021-07-01 → 2021-09-30¥805m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue external2021-07-01 → 2021-09-30¥805m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentsegment profit2021-07-01 → 2021-09-30−¥209m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue2021-07-01 → 2021-09-30¥184m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue external2021-07-01 → 2021-09-30¥181m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥3m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentsegment profit2021-07-01 → 2021-09-30¥34m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue2021-07-01 → 2021-09-30¥149m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue external2021-07-01 → 2021-09-30¥149m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentsegment profit2021-07-01 → 2021-09-30¥22m
—segment totalrevenue2021-07-01 → 2021-09-30¥2.6bn
—segment totalrevenue external2021-07-01 → 2021-09-30¥2.6bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥3m
—segment totalsegment profit2021-07-01 → 2021-09-30¥145m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 311
ItemContextValueUnit
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember600000JPY
Revenues from external customersCurrentYTDDuration2216881000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05367-000ClinicalEvidenceServiceReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05367-000HealthCareSupportServiceReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalFoodRetailingReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05367-000ClinicalEvidenceServiceReportableSegmentsMember89113000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05367-000HealthCareSupportServiceReportableSegmentsMember147686000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember1109694000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalFoodRetailingReportableSegmentsMember732053000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember137732000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember2216281000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember600000JPY
Net salesCurrentYTDDuration2216881000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05367-000ClinicalEvidenceServiceReportableSegmentsMember-12610000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05367-000HealthCareSupportServiceReportableSegmentsMember15153000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember282401000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalFoodRetailingReportableSegmentsMember-184324000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember22552000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember123172000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-77225000JPY
Operating incomeCurrentYTDDuration45946000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)近畿財務局長
Filing date cover pageFilingDateInstant2022-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第29期第１四半期（自　2022年７月１日　至　2022年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社総医研ホールディングス
Company name in english cover pageFilingDateInstantSoiken Holdings Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　石神　賢太郎
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪府豊中市新千里東町一丁目４番２号
Telephone number address of registered headquarter cover pageFilingDateInstant06（6871）8888
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役財務部長　　十河　健一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪府豊中市新千里東町一丁目４番２号
Telephone number nearest place of contact cover pageFilingDateInstant06（6871）8888
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役財務部長　　十河　健一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE05367
Fund codeFilingDateInstant－
Security codeFilingDateInstant23850
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社総医研ホールディングス
Filer name in englishFilingDateInstantSoiken Holdings Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-06-30pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass